Physician profile
Charles Rogers
NPI 1073619078
$2,559.70
in general payments reported to CMS, 2019-2025
25 companies · $1,567 in 2025
The $1,567 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $148 · 2021: $367 · 2022: $192 · 2023: $50.47 · 2024: $23.32 · 2025: $1,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Food and Beverage | $140.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,500.00 | 2025 | |
| Abbvie INC. | $273.05 | 2019-2022 | |
| Pfizer INC. | $202.56 | 2019-2023 | |
| Astellas Pharma US INC | $99.89 | 2019-2021 | |
| Therapeuticsmd, INC. | $49.32 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.08 | 2019-2025 | |
| Mylan Pharmaceuticals INC. | $41.66 | 2021-2022 | |
| Hologic Sales and Service, LLC | $41.62 | 2019-2025 | Aptima |
| Baxter Healthcare | $36.21 | 2021 | |
| Mayne Pharma Commercial LLC | $35.63 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $30.06 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $25.54 | 2021-2022 | |
| Coloplast Corp | $20.68 | 2019 | |
| Medtronic, INC. | $17.83 | 2021 | |
| Radius Health, INC. | $17.59 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $15.07 | 2019 | |
| Duchesnay USA Incorporated | $14.53 | 2019 | |
| Amgen INC. | $13.96 | 2023 | Prolia, Evenity |
| Davol INC. | $13.75 | 2021 | |
| Amag Pharmaceuticals, INC. | $13.69 | 2019 | |
| Mission Pharmacal Company | $13.08 | 2020 | |
| Agile Therapeutics, INC. | $11.88 | 2022 | |
| Coopersurgical, INC. | $11.70 | 2022 | |
| Novo Nordisk INC | $11.32 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.